Indi Molecular scores $1.5 mln in seed funding

Indi Molecular said Friday that it has closed $1.5 million in seed funding. InterWest Partners led the round with participation from several unidentified angel investors. Headquartered in Culver City, Calif., Indi Molecular, which was spun out from Integrated Diagnostics, is a life sciences company that has developed a synthetic replacement for antibodies.

North AmericaUSBriefs